RxDoctor Payments Data

Luis Ortega, MD

Cardiovascular Disease · Jacksonville, FLNPI 1124745351

Payments from drug & device makers

$212,097in general payments, 2019–2025

Across 102 payments — averaging $2079.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$117K
  • Cleerly, Inc.$67K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$25K
  • Ionis Pharmaceuticals, Inc.$3K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$212,097 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$52,427
Medicare patients
336
Services billed
683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium11$163
Losartan Potassium13$73

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →